Shahid Beheshti University of Medical Science
Tehran, 4739-19395, Iran
NCT Number: NCT06361953
Generalized anxiety disorder (GAD) is one of the most prevalent mental disorders in adults, marked by excessive and uncontrollable worry about various events or activities. It is accompanied by symptoms such as restlessness, irritability, fatigue, difficulty concentrating, problems with sleep, and somatic symptoms.
In addition, a critical and up-to-date comparison of different treatments for GAD is crucial due to their high costs and unsatisfactory outcomes. EEG neurofeedback training has not reached the same level of evidence as more extensively validated non-pharmacological treatments, such as cognitive behavioral therapy.This study aimed to compare the efficacy of two protocols: one targeting alpha-theta amplitude increase and the other concentrating on SMR.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Tehran, 4739-19395, Iran
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
neurofeedback training over five weeks, comprising 15 sessions. Each neurofeedback training session lasted 30 minutes.
Time frame: Pre-test, after 5 weeks and two month follow up
higher scores mean higher depression
Time frame: Pre-test, after 5 weeks and two month follow up
higher scores mean higher stress
Time frame: Pre-test, after 5 weeks and two month follow up
higher scores mean higher anxiety
Shahid Beheshti University of Medical Sciences
Other
Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder: Sensory Motor Rhythm and Alpha-Theta
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05970510
Anxiety Disorders, Generalized Anxiety Disorder
Beijing, China
View Trial DetailsNCT05503017
Anxiety Disorders, Generalized Anxiety Disorder
Tallahassee, Florida, United States
View Trial DetailsNCT03585010
Anxiety Disorder of Childhood, Anxiety Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT06124014
Anxiety Disorders, Generalized Anxiety Disorder
Chapel Hill, North Carolina, United States
View Trial Details